Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123987973 | 12398797 | 3 | F | 2016 | 20160801 | 20160524 | 20160805 | EXP | US-PFIZER INC-2016270979 | PFIZER | 66.00 | YR | F | Y | 0.00000 | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123987973 | 12398797 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | 5 MG, 2X/DAY | M8637 | 203214 | 5 | MG | TABLET | BID | ||||||
| 123987973 | 12398797 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | 203214 | TABLET | |||||||||||
| 123987973 | 12398797 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 20 MG, WEEKLY | 11719 | 20 | MG | /wk | ||||||||
| 123987973 | 12398797 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 11719 | ||||||||||||
| 123987973 | 12398797 | 5 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, 1X/DAY | 18667 | 20 | MG | QD | ||||||||
| 123987973 | 12398797 | 6 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, 2X/DAY | 18667 | 20 | MG | BID | ||||||||
| 123987973 | 12398797 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | 5 MG, 2X/DAY | 0 | 5 | MG | BID | ||||||||
| 123987973 | 12398797 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 123987973 | 12398797 | 9 | SS | SOMA | CARISOPRODOL | 1 | 800 MG, 4X/DAY | 0 | 800 | MG | QID | ||||||||
| 123987973 | 12398797 | 10 | SS | MEPROBAMATE. | MEPROBAMATE | 1 | UNK | 0 | |||||||||||
| 123987973 | 12398797 | 11 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
| 123987973 | 12398797 | 12 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
| 123987973 | 12398797 | 13 | C | METOLAZONE. | METOLAZONE | 1 | 2.5 MG, AS NEEDED | 0 | 2.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123987973 | 12398797 | 1 | Swelling |
| 123987973 | 12398797 | 2 | Pain |
| 123987973 | 12398797 | 3 | Systemic lupus erythematosus |
| 123987973 | 12398797 | 4 | Swelling |
| 123987973 | 12398797 | 5 | Swelling |
| 123987973 | 12398797 | 7 | Osteoporosis |
| 123987973 | 12398797 | 8 | Swelling |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123987973 | 12398797 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123987973 | 12398797 | Arthralgia | |
| 123987973 | 12398797 | Bowel movement irregularity | |
| 123987973 | 12398797 | Diarrhoea | |
| 123987973 | 12398797 | Flatulence | |
| 123987973 | 12398797 | Pain in extremity | |
| 123987973 | 12398797 | Peripheral swelling | |
| 123987973 | 12398797 | Pollakiuria | |
| 123987973 | 12398797 | Rash | |
| 123987973 | 12398797 | Rash maculo-papular | |
| 123987973 | 12398797 | Scratch | |
| 123987973 | 12398797 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123987973 | 12398797 | 5 | 20160425 | 0 |